Mind map
Serum lipids

Map content
Serum lipids
Plasma lipid composition
- triacylglycerols (16%)
- phospholipids (30%)
- cholesterol (14%)
- cholesteryl esters (36%)
- unesterified long-chain fatty acids (or FFAs) (4%)
- metabolically the most active plasma lipid
- from peripheral adipocytes to other tissues.
- metabolically the most active plasma lipid
Lipoproteins
- complexes of lipid & protein molecules
- Major groups
- chylomicrons
- derived from intestinal absorption of
- dietary triacylglycerol
- other lipids
- main apoprotein
- apo B (B-48)
- 48% of apo B-100
- from B-100 synthesized in the liver
- synthesized in the intestine
- 48% of apo B-100
- apo B (B-48)
- derived from intestinal absorption of
- VLDL very-low-density lipoprotein
- derived from the liver
- endogenous triacylglycerol exportation
- pre-β-lipoprotein
- cholesterol
- main apoprotein
- apo B
- derived from the liver
- LDL low-density lipoprotein
- final stage of VLDL catabolism
- cholesterol
- main apoprotein
- apo B-100
- β-lipoprotein
- HDL high-density lipoproteins
- cholesterol and phospholipids transport
- metabolism of
- VLDL
- chylomicron
- Source
- Liver
- intestine
- VLDL
- chylomicrons
- main apoprotein
- apo As
- α-lipoprotein
- IDL intermediate-density lipoprotein
- Triacylglycerol
- cholesterol
- main apolipoprotein
- apo B
- chylomicrons
- Composition
- nonpolar lipid core
- triacylglycerol
- cholesteryl ester
- single surface layer
- amphipathic phospholipids
- cholesterol
- protein moiety
- Apoproteins
- Roles
- form lipoprotein structure
- enzyme cofactors
- C-II
- lipoprotein lipase
- A-I
- lecithin:cholesterol acyltransferase LCAT
- C-II
- enzyme inhibitors
- apo A-II
- lipoprotein lipase
- apo C-III
- lipoprotein lipase
- apo C-I
- cholesteryl ester transfer protein
- apo A-II
- act as ligands
- for lipoprotein receptors in tissues
- apo B-100
- LDL receptor
- apo E
- LDL receptor
- LDL-receptor–related protein-1 (LRP-1)
- recognizes remnant lipoproteins
- apo A-I
- HDL receptor
- apo B-100
- for lipoprotein receptors in tissues
- apo A-IV
- chylomicron metabolism
- regulator
- satiety
- glucose homeostasis
- therapeutic target for treatment
- diabetes
- obesity
- apo D
- factor in neurodegenerative disorders.
- location
- integral
- cannot be removed
- apo B
- cannot be removed
- peripheral
- can transfer to other lipoproteins
- apo C
- C-I
- C-II
- C-III
- apo E
- VLDL
- HDL
- chylomicrons & remnants
- apo C
- can transfer to other lipoproteins
- integral
- Roles
- Apoproteins
- nonpolar lipid core
- Function
- transportation and delivery
- fatty acids
- triacylglycerol
- cholesterol
- transportation and delivery
- Hepatocytes and intestinal epithelial cells
- use cholesterol for their secretion
- Major groups
- complexes of lipid & protein molecules
Metabolism of Triglyceride Rich Lipoproteins in Plasma
- Hydrolysis by lipoprotein lipase
- Lipoprotein lipase enzyme in capillaries endothelium
- Location
- heart
- low Km
- Result
- fatty acids from adipose tissue
- head to the heart in the starved state
- when plasma triacylglycerol decreases
- head to the heart in the starved state
- fatty acids from adipose tissue
- Result
- low Km
- adipose tissue
- high Km
- Result
- VLDL receptor
- VLDL binding
- fatty acids from VLDL triacylglycerol to adipocytes
- VLDL binding
- insulin enhances
- lipoprotein lipase synthesis
- translocation to capillary endothelium
- lipoprotein lipase synthesis
- high Km
- spleen
- lung
- renal medulla
- aorta
- diaphragm
- lactating mammary gland
- fatty acid uptake
- milk fat synthesis
- fatty acid uptake
- skeletal muscle
- heart
- cofactors
- phospholipids
- apo CII
- heparin
- inhibitors
- apo AII
- apo CIII
- increases VLDL production
- hydrolysis of lipoproteins attached to the enzyme
- Triacylglycerol from chylomicrons & VLDL
- diacylglycerol
- monoacylglycerol
- FFA
- some return to the circulation
- attached to albumin
- majority transported into the tissue
- some return to the circulation
- glycerol
- FFA
- monoacylglycerol
- diacylglycerol
- Formation of lipoprotein remnants
- Loss of
- 70-90% of triacylglycerides
- chylomicron remnant
- half the diameter of the parent chylomicron
- enriched in cholesterol and cholesteryl esters
- taken up by the liver by endocytosis
- cholesteryl esters and triacylglycerols are hydrolyzed and metabolized
- free cholesterol
- supressses cholesterol biosynthesis (downregulates HMGCoA)
- LDL receptor supression & degradation
- free cholesterol
- Uptake mediated by
- apo E dependent receptors
- LDL (apo B100, E) receptor
- LDL receptor–related protein1 (LRP1)
- require
- Apo E3
- Apo E4
- apo E dependent receptors
- B48 is degraded
- cholesteryl esters and triacylglycerols are hydrolyzed and metabolized
- taken up by the liver by endocytosis
- enriched in cholesterol and cholesteryl esters
- half the diameter of the parent chylomicron
- VLDL remnants
- intermediate-density lipoprotein (IDL)
- taken up by the liver
- LDL (apo B100, E) receptor
- mostly metabolized to LDL in the circulation
- involves removal of residual triglycerides by hepatic lipase
- beta shift (high LDL)
- plasma LDL accumulation
- Content
- one apo B100 is conserved
- cholesteryl esters
- hypertriglyceridemic states
- low conversion to LDL
- taken up by the liver
- intermediate-density lipoprotein (IDL)
- chylomicron remnant
- apo C
- returns to HDL
- 70-90% of triacylglycerides
- Loss of
- Triacylglycerol from chylomicrons & VLDL
- GPIHPB1 organizes the complex
- Lipase maturation factor 1 (LMF1)
- lipoprotein lipase
- endothelial lipase
- hepatic lipase
- acts as a ligand for remnant uptake
- hydrolyzes
- remnant triacylglycerol & phospholipid
- Location
- Lipoprotein lipase enzyme in capillaries endothelium
- Biologic regulation of lipoprotein lipase
- insulin
- LPL is transcriptionally upregulated in adipose tissue
- fatty acid storage
- LPL is transcriptionally upregulated in adipose tissue
- prolonged fasting
- adipose tissue LPL activity falls
- diabetic ketoacidosis
- adipose tissue LPL activity falls
- prevents fatty acid storage
- adipose tissue LPL activity falls
- insulin
- Effect of dietary fat restriction
- normally: 75 -100 g of triglyceride in chylomicrons a day
- liver exports 10-30g in VLDL.
- At triglyceride levels 800 -1000 mg/dL
- LPL saturation
- acute restriction of dietary fat is necessary
- LPL saturation
- At triglyceride levels 800 -1000 mg/dL
- liver exports 10-30g in VLDL.
- normally: 75 -100 g of triglyceride in chylomicrons a day
- lipoprotein half live
- chylomicrons
- 5 -20 min
- VLDL
- 0.5 -1 h
- LDL
- 2½ days
- chylomicrons
- Hydrolysis by lipoprotein lipase
Metabolism of HighDensity Lipoproteins
- Sources of HDL
- produce HDL apolipoproteins
- liver
- intestine
- chylomicrons and VLDL hydrolysis of triglycerides
- liberated excess free cholesterol and phospholipids
- phospholipid transfer protein
- transfers phospholipids to HDL
- Free cholesterol acquired by HDL
- esterified by LCAT secreted by liver
- 1 mol of fatty acid from lecithin
- to the hydroxyl group of unesterified cholesterol
- cholesteryl esters
- to the hydroxyl group of unesterified cholesterol
- 1 mol of fatty acid from lecithin
- esterified by LCAT secreted by liver
- phospholipid transfer protein
- liberated excess free cholesterol and phospholipids
- produce HDL apolipoproteins
- Metabolic roles for HDL
- HDL are carriers of C apolipoproteins
- transfer apo C to nascent VLDL & chylomicrons
- deliver cholesterol with LDL
- adrenal cortex
- gonads
- steroidogenesis
- centripetal cholesterol transport
- Unesterified cholesterol exported by ABCA1
- acquired from tissues membranes by prebeta1 HDL
- esterified by LCAT
- passing through other HDL
- before the cholesteryl esters are incorporated into α-HDL
- passing through other HDL
- esterified by LCAT
- acquired from tissues membranes by prebeta1 HDL
- Cholesterol effluxed from macrophages by ABCG1
- acquired by larger HDL
- cholesteryl esters transferred to
- LDL & triglyceride rich lipoproteins
- by cholesteryl ester transfer protein (CETP)
- hepatocytes
- by SRB1 receptors
- excretion via the bile
- reverse cholesterol transport
- excretion via the bile
- by SRB1 receptors
- LDL & triglyceride rich lipoproteins
- Unesterified cholesterol exported by ABCA1
- HDL are carriers of C apolipoproteins
- HDL catabolism
- pathways are not yet known
- Apo AI & Apo A-II removed from plasma
- degradation in
- liver
- kidney
- degradation in
- Apo AI & Apo A-II removed from plasma
- pathways are not yet known
- Sources of HDL
Images and files in the map
Information
- Description
- Medicina Mind Map on Serum lipids, created by Valentina Ardila Mora on 11/10/2020.
- Created by
- Valentina Ardila Mora
- Views
- 0
- Rating


